Literature DB >> 9164422

Nitric oxide and shock.

R G Kilbourn1, D L Traber, C Szabó.   

Abstract

Shock can be defined as the failure of the circulatory system to provide necessary cellular nutrients, including oxygen, and to remove metabolic wastes. Although it is now recognized that more than 100 different forms of shock exist, this recognition is more a reflection of the widespread use of the term to describe a variety of disease states. For the purpose of this monograph, we concentrate on various forms of cardiovascular shock, in particular, shock that may be linked to inappropriate vasodilation from overproduction of the endogenous vasodilator, nitric oxide. Some forms of shock have been extensively studied, and convincing evidence exists for the role of nitric oxide. Other disease states have been less well characterized in terms of their association with excess nitric oxide production. Available evidence of a role for nitric oxide is discussed in the hope of stimulating the interest of investigators to explore these areas more thoroughly.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9164422     DOI: 10.1016/s0011-5029(97)90028-6

Source DB:  PubMed          Journal:  Dis Mon        ISSN: 0011-5029            Impact factor:   3.800


  13 in total

1.  The control of hepatic glycogen metabolism in an in vitro model of sepsis.

Authors:  Jennifer Wallington; Jian Ning; Michael Alan Titheradge
Journal:  Mol Cell Biochem       Date:  2007-10-13       Impact factor: 3.396

2.  Recombinant osteopontin attenuates brain injury after intracerebral hemorrhage in mice.

Authors:  Bihua Wu; Qingyi Ma; Hidenori Suzuki; Chunhua Chen; Wenwu Liu; Jiping Tang; John Zhang
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

Review 3.  Pathophysiological roles of peroxynitrite in circulatory shock.

Authors:  Csaba Szabó; Katalin Módis
Journal:  Shock       Date:  2010-09       Impact factor: 3.454

4.  Peripheral photoplethysmography variability analysis of sepsis patients.

Authors:  Paul M Middleton; Collin H H Tang; Gregory S H Chan; Sarah Bishop; Andrey V Savkin; Nigel H Lovell
Journal:  Med Biol Eng Comput       Date:  2010-12-14       Impact factor: 2.602

Review 5.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

6.  Characterization of short range DNA looping in endotoxin-mediated transcription of the murine inducible nitric-oxide synthase (iNOS) gene.

Authors:  Hongtao Guo; Zhiyong Mi; Paul C Kuo
Journal:  J Biol Chem       Date:  2008-07-02       Impact factor: 5.157

7.  Stat1 acetylation inhibits inducible nitric oxide synthase expression in interferon-gamma-treated RAW264.7 murine macrophages.

Authors:  Lucie Guo; Hongtao Guo; Chengjiang Gao; Zhiyong Mi; William B Russell; Paul C Kuo
Journal:  Surgery       Date:  2007-08       Impact factor: 3.982

8.  Osteopontin mediates Stat1 degradation to inhibit iNOS transcription in a cecal ligation and puncture model of sepsis.

Authors:  Hongtao Guo; Philip Y Wai; Zhiyong Mi; Chengjiang Gao; Jinping Zhang; Paul C Kuo
Journal:  Surgery       Date:  2008-05-16       Impact factor: 3.982

Review 9.  Tetrahydrobiopterin in cardiovascular health and disease.

Authors:  Jennifer K Bendall; Gillian Douglas; Eileen McNeill; Keith M Channon; Mark J Crabtree
Journal:  Antioxid Redox Signal       Date:  2014-03-14       Impact factor: 8.401

10.  Curbing inflammation in the ischemic heart disease.

Authors:  Paulo Roberto B Evora; Julio Nather; Paulo Victor Tubino; Agnes Afrodite S Albuquerque; Andrea Carla Celotto; Alfredo J Rodrigues
Journal:  Int J Inflam       Date:  2013-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.